Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells

Virology Journal

Volumn 10, Issue , 2013, Pages

  Yang, Hong Jie ^a   Huang, Tie Jun ^b   Yang, Chang Fu ^c,d   Peng, Li Xia ^a   Liu, Ran Yi ^a   Yang, Guang Da ^a   Chu, Qiao Qiao ^f   Huang, Jia Ling ^e   Liu, Na ^a   Huang, Hong Bing ^a   Zhu, Zhen Yu ^d   Qian, Chao Nan ^a   Huang, Bi Jun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Second People's Hospital of Shenzhen   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d SUN YAT SEN UNIVERSITY   (China)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f SUN YAT SEN UNIVERSITY   (China)

Author keywords

Burkitt's lymphoma; Epstein Barr virus; Latency types; Nasopharyngeal carcinoma; Viral microRNA

Indexed keywords

EPSTEIN BARR VIRUS ENCODED MICRORNA; MICRORNA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DAUDI CELL; DNA SEQUENCE; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMAN TISSUE; LATENT PERIOD; MICROARRAY ANALYSIS; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

BIOPSY; CELLS, CULTURED; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA, LYMPHOID; MICROARRAY ANALYSIS; MICRORNAS; NEOPLASMS, GLANDULAR AND EPITHELIAL; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRUS LATENCY;

EID: 84886108214     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-314     Document Type: Article

References (62)

1. The Epstein-Barr virus and its association with human cancers. Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG, Mol Pathol 1999 52 307 322 10.1136/mp.52.6.307 10748864 (Pubitemid 30002763)
2. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Niedobitek G, Mol Pathol 2000 53 248 254 10.1136/mp.53.5.248 11091848
3. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N, N Engl J Med 1995 333 693 698 10.1056/NEJM199509143331103 7637746
4. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To KF, Hayward DS, Chui YL, Lau YL, Takada K, Huang DP, Neoplasia 2006 8 173 180 10.1593/neo.05625 16611410 (Pubitemid 43671232)
5. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao G, Hayward SD, Proc Natl Acad Sci USA 2007 104 16164 16169 10.1073/pnas.0702896104 17911266 (Pubitemid 350099379)
6. Identification of virus-encoded microRNAs. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T, Science 2004 304 734 736 10.1126/science.1096781 15118162 (Pubitemid 38560879)
7. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, Jaker C, Hock J, Meister G, Grasser FA, Nucleic Acids Res 2008 36 666 675 18073197 (Pubitemid 351250456)
8. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF, Kwong DL, Tsao SW, Jin DY, J Exp Med 2008 205 2551 2560 10.1084/jem.20072581 18838543
9. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O, Cell Host Microbe 2009 5 376 385 10.1016/j.chom.2009. 03.003 19380116
10. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. Seto E, Moosmann A, Gromminger S, Walz N, Grundhoff A, Hammerschmidt W, PLoS Pathog 2010 6 1001063 10.1371/journal.ppat.1001063 20808852
11. Host immune system gene targeting by a viral miRNA. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, et al. Science 2007 317 376 381 10.1126/science.1140956 17641203 (Pubitemid 47106378)
12. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M, et al. Cancer Res 2008 68 1436 1442 10.1158/0008-5472.CAN-07-5126 18316607 (Pubitemid 351346851)
13. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Hansen A, Henderson S, Lagos D, Nikitenko L, Coulter E, Roberts S, Gratrix F, Plaisance K, Renne R, Bower M, et al. Genes Dev 2010 24 195 205 10.1101/gad.553410 20080955
14. Virus-specific host miRNAs: antiviral defenses or promoters of persistent infection? Mahajan VS, Drake A, Chen J, Trends Immunol 2009 30 1 7 10.1016/j.it.2008.08.009 19059006
15. Viral latency and its regulation: lessons from the gamma-herpesviruses. Speck SH, Ganem D, Cell Host Microbe 2010 8 100 115 10.1016/j.chom.2010.06.014 20638646
16. Noncoding RNAs produced by oncogenic human herpesviruses. Swaminathan S, J Cell Physiol 2008 216 321 326 10.1002/jcp.21480 18484093 (Pubitemid 351898457)
17. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Bellare P, Ganem D, Cell Host Microbe 2009 6 570 575 10.1016/j.chom.2009.11.008 20006845
18. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Murphy E, Vanicek J, Robins H, Shenk T, Levine AJ, Proc Natl Acad Sci U S A 2008 105 5453 5458 10.1073/pnas.0711910105 18378902 (Pubitemid 351753884)
19. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR, Nature 2008 454 780 783 18596690
20. Viral and cellular messenger RNA targets of viral microRNAs. Cullen BR, Nature 2009 457 421 425 10.1038/nature07757 19158788
21. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D, Nature 2005 435 682 686 10.1038/nature03576 15931223 (Pubitemid 40825513)
22. Transcripts from the Epstein-Barr virus BamHI a fragment are detectable in all three forms of virus latency. Brooks LA, Lear AL, Young LS, Rickinson AB, J Virol 1993 67 3182 3190 8388496 (Pubitemid 23143688)
23. Biology and disease associations of Epstein-Barr virus. Crawford DH, Philos Trans R Soc Lond B Biol Sci 2001 356 461 473 10.1098/rstb.2000.0783 11313005 (Pubitemid 32442746)
24. Visualization of alternative Epstein-Barr virus expression programs by fluorescent in situ hybridization at the cell level. Szeles A, Falk KI, Imreh S, Klein G, J Virol 1999 73 5064 5069 10233969 (Pubitemid 29246768)
25. The expression and function of Epstein-Barr virus encoded latent genes. Young LS, Dawson CW, Eliopoulos AG, Mol Pathol 2000 53 238 247 10.1136/mp.53.5.238 11091847
26. Regulation of expression of the Epstein-Barr virus BamHI-a rightward transcripts. Chen H, Huang J, Wu FY, Liao G, Hutt-Fletcher L, Hayward SD, J Virol 2005 79 1724 1733 10.1128/JVI.79.3.1724-1733.2005 15650197 (Pubitemid 40459118)
27. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. Edwards RH, Marquitz AR, Raab-Traub N, J Virol 2008 82 9094 9106 10.1128/JVI.00785-08 18614630
28. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Cameron JE, Fewell C, Yin Q, McBride J, Wang X, Lin Z, Flemington EK, Virology 2008 382 257 266 10.1016/j.virol.2008.09.018 18950829
29. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM, Nature 2005 433 769 773 10.1038/nature03315 15685193 (Pubitemid 40292988)
30. A custom microarray platform for analysis of microRNA gene expression. Thomson JM, Parker J, Perou CM, Hammond SM, Nat Methods 2004 1 47 53 10.1038/nmeth704 15782152
31. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. Chen SJ, Chen GH, Chen YH, Liu CY, Chang KP, Chang YS, Chen HC, PLoS One 2010 5 9 12745 10.1371/journal.pone.0012745 20862214
32. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR, PLoS Pathog 2006 2 23 10.1371/journal.ppat. 0020023 16557291
33. A novel qPCR assay for viral encoded microRNAs. Reichenstein I, Aizenberg N, Goshen M, Bentwich Z, Avni YS, J Virol Methods 2010 163 323 328 10.1016/j.jviromet.2009.10.018 19879298
34. Analyzing real-time PCR data by the comparative C(T) method. Schmittgen TD, Livak KJ, Nat Protoc 2008 3 1101 1108 10.1038/nprot.2008.73 18546601 (Pubitemid 351818697)
35. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB, Rowe M, PLoS Pathog 2009 5 1000341 10.1371/journal. ppat.1000341 19283066
36. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S, Takada K, EMBO J 2000 19 6742 6750 10.1093/emboj/19.24.6742 11118209 (Pubitemid 32011667)
37. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B, Virology 2009 386 387 397 10.1016/j.virol.2009.01.006 19217135
38. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC, Int J Cancer 1999 83 121 126 10.1002/(SICI)1097- 0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F 10449618 (Pubitemid 29409487)
39. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, Cullen BR, Delecluse HJ, PLoS Pathog 2011 7 1001294 10.1371/journal.ppat. 1001294 21379335
40. Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. Xing L, Kieff E, J Virol 2007 81 9967 9975 10.1128/JVI.02244-06 17626073 (Pubitemid 350067700)
41. Sequence analysis of the 17,166 base-pair EcoRI fragment C of B95-8 Epstein-Barr virus. Bankier AT, Deininger PL, Farrell PJ, Barrell BG, Mol Biol Med 1983 1 21 45 6092825 (Pubitemid 14143199)
42. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Raab-Traub N, Dambaugh T, Kieff E, Cell 1980 22 257 267 10.1016/0092-8674(80)90173-7 6253079 (Pubitemid 11226447)
43. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Fernandez AF, Rosales C, Lopez-Nieva P, Grana O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, et al. Genome Res 2009 19 438 451 19208682
44. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Sengupta S, den Boon JA, Chen IH, Newton MA, Dahl DB, Chen M, Cheng YJ, Westra WH, Chen CJ, Hildesheim A, et al. Cancer Res 2006 66 7999 8006 10.1158/0008-5472.CAN-05-4399 16912175 (Pubitemid 44299164)
45. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, Middeldorp J, Thorley-Lawson DA, J Virol 2009 83 2357 2367 10.1128/JVI.02104-08 19091858
46. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, Grasser F, Meister G, J Virol 2009 83 3333 3341 10.1128/JVI.01689-08 19144710
47. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. Sotiropoulou G, Pampalakis G, Lianidou E, Mourelatos Z, RNA 2009 15 1443 1461 10.1261/rna.1534709 19561119
48. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW, Nature 2006 442 82 85 16738545 (Pubitemid 44064213)
49. HIV-1 encoded candidate micro-RNAs and their cellular targets. Bennasser Y, Le SY, Yeung ML, Jeang KT, Retrovirology 2004 1 43 10.1186/1742-4690-1-43 15601472 (Pubitemid 40617928)
50. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H, Nat Med 2007 13 1241 1247 10.1038/nm1639 17906637 (Pubitemid 47530631)
51. Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing. Gitlin L, Andino R, J Virol 2003 77 7159 7165 10.1128/JVI.77.13.7159-7165.2003 12805414 (Pubitemid 36734484)
52. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, Hatzigeorgiou A, Iwakiri D, Takada K, Wiedmer A, Showe L, et al. J Biol Chem 2010 285 33358 33370 10.1074/jbc.M110.138362 20716523
53. Viruses and microRNAs. Cullen BR, Nat Genet 2006 38 Suppl 25 S30 16736021
54. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Gottwein E, Cullen BR, Cell Host Microbe 2008 3 375 387 10.1016/j.chom.2008.05.002 18541214 (Pubitemid 351773098)
55. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains. Fresen KO, Hausen H, Int J Cancer 1976 17 161 6 10.1002/ijc.2910170203 175026
56. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Takada K, Horinouchi K, Ono Y, Aya T, Osato T, Takahashi M, Hayasaka S, Virus Genes 1991 5 147 56 10.1007/BF00571929 1647567
57. A study of malignant tumours in nigeria by short-term tissue culture. Pulvertaft JV, J Clin Pathol 1965 18 261 73 10.1136/jcp.18.3.261 14304234
58. Sensitivity of Epstein-Barr virus (EBV)producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Klein G, Dombos L, Gothoskar B, Int J Cancer 1972 10 44 57 10.1002/ijc.2910100108 4122458
59. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference. Miller G, Robinson J, Heston L, Lipman M, IARC Sci Publ 1975 11 1 395 408 190145
60. A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome. Wang HY, Luo M, Tereshchenko IV, Frikker DM, Cui X, Li JY, Hu G, Chu Y, Azaro MA, Lin Y, et al. Genome Res 2005 15 276 283 10.1101/gr.2885205 15687291 (Pubitemid 40309392)
61. Direct and sensitive miRNA profiling from low-input total RNA. Wang H, Ach RA, Curry B, RNA 2007 13 151 159 17105992 (Pubitemid 46026189)
62. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Chen HC, Chen GH, Chen YH, Liao WL, Liu CY, Chang KP, Chang YS, Chen SJ, Br J Cancer 2009 100 1002 1011 10.1038/sj.bjc.6604948 19293812